Research and Markets: 2015 European Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape

Research and Markets (http://www.researchandmarkets.com/research/42ks3w/2015_european) has announced the addition of the "2015 European Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape" report to their offering.

This report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.

The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

Report Highlights:

• Business and technological trends in major markets
• Five-year test volume and sales forecasts
• Market shares of leading competitors
• Feature comparison of major analyzers
• Strategic profiles of leading market players and start-up firms developing innovative products
• Specific product and business opportunities for instrument and consumable suppliers.
  

Scope of the Report:

Geographic Coverage:

• France
• Germany
• Italy
• Spain
• UK
  

European Market Overview:

• Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by country and market segment.
• Five-year test volume and sales projections by country.
  

Product/Technology Review:

• Comparison of leading infectious disease molecular diagnostic analyzers.
• Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.
• Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products.
  

Competitive Assessments:

• Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
• Comprehensive listings of companies developing and marketing infectious disease molecular diagnostic products, by test and application.
  

Opportunities and Strategic Recommendations:

• Specific new product development opportunities with potentially significant market appeal during the next five years.
• Design criteria for new products.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.
• Business planning issues and concerns.
  

30 of 40+ Companies Mentioned:

• Abbott
• Affymetrix
• Agilent Technologies
• Applied Gene Technologies
• Arca Biopharma
• Beckman Coulter/Danaher
• Becton Dickinson
• Biokit
• bioMerieux
• Bio-Rad
• Biotest
• Cepheid
• CellMark Forenciscs/LabCorp
• Decode Genetics
• Diadexus
• Eiken
• Elitech Group
• Enzo
• Exact Sciences
• Fujirebio
• Grifols
• Hologic/Gen-Probe
• Illumina
• Kreatech/Leica
• Li-Cor Biosciences
• Monogram Biosciences/LabCorp
• Myriad Genetics
• Ortho-Clinical Diagnostics
• Perkin Elmer/Caliper
• Proteome Sciences
  

For more information visit http://www.researchandmarkets.com/research/42ks3w/2015_european

View source version on businesswire.com: http://www.businesswire.com/news/home/20151127005135/en/